What Is-Jdrf-Delaware-Improve Lives
Just go to http://yourdonationcounts.jdrftype1.com
See full list of Media Credits http://broadcaster.beazil.net/public/credits/youtube/videos/43699 Delaware city, seat (1808) of Delaware county, central Ohio, U.S. It lies along the Olentangy River, 25 miles (40 km) north of Columbus. The Delaware Indians had a village in the vicinity before Col. Moses Byxbe of Massachusetts settled on the east bank of the river in 1804. The town was laid out in 1808 and became a popular health resort because of its close proximity to a sulfur spring. Ohio Wesleyan University (1842) was built around the town’s Mansion House (now Elliot Hall). The Methodist Theological School in Ohio was opened in Delaware in 1960. Perkins Observatory, maintained by Ohio Wesleyan University, is 4 miles (6 km) south of the city. A stone monument marks the birthplace of U.S. president Rutherford B. Hayes. After World War II there was some industrial growth; the city’s manufactures now include industrial and automotive coatings, copper products, stone and concrete, tools and dies, building materials, and chemicals. Type 1 diabetes in children used to be known as juvenile diabetes or insulin-dependent diabetes. Alternative Names of T1D: Insulin-dependent diabetes; Juvenile onset diabetes; Diabetes – type 1. Type 1 Diabetes – In type 1 diabetes, your immune system mistakenly destroys the cells in your pancreas that make insulin. Your body treats these cells as invaders and destroys them. This can happen over a few weeks, months, or years. When enough beta cells are destroyed, your pancreas stops making insulin, or makes too little insulin. Because the pancreas does not make insulin, insulin needs to be replaced. Insulin does not come in a pill. People with type 1 diabetes take insulin by injection with a syringe, an insulin pen, or an insulin pump. Without insulin, your blood glucose rises and is higher than normal, which is called hyperglycemia. Type 1 diabetes affects about 5% of people in the United States with diabetes. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF prioritizes its funding for type 1 diabetes research in four interrelated therapeutic areas: autoimmune therapies, β-cell therapies, prevention of complications, and glucose control. Each therapeutic area encompasses a diverse portfolio of research programs that span from exploratory to preclinical proof-of-principle and on to clinical proof-of-concept research. The organization’s overarching strategy focuses on addressing critical gaps and challenges, catalyzing innovative and transformational research, advancing and translating research, creating collaborations, and accelerating time lines at all stages of research development. To facilitate downstream partnering and follow-on funding, JDRF increasingly supports product development by “de-risking” projects, thereby decreasing the barriers of entry for future funders. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
See more about it http://jdrf.org/blog/
Subscribe to our Google Plus account https://plus.google.com/110620633690555176280/
Appreciate our videos at https://www.youtube.com/user/jdrfonline
Go to our Facebook account https://www.facebook.com/myJDRF
Check our Twitter account https://twitter.com/JDRFTypeOne
Join us at our Linkedin account https://www.linkedin.com/company/jdrf
Subscribe at our Instagram account https://www.instagram.com/jdrfadvocacy/
Join us at our Pinterest account https://www.pinterest.com/jdrfadvocacy/
In summary, here are the main points:
prone to ketoacidosis,at-risk relatives,noninsulin-dependent diabetes mellitus,amputation,A1C complications,DPP,diabetic kidney disease,Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation Trial,Research Summit,MODY,insulin.